SCHEMBL9748135

SCHEMBL9748135

COC(=O)c1ccc(CSc2nc(C)cs2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.64
SMN1; SMN2 Q16637 7/20 0.64
NPC1 O15118 7/20 0.64
ALDH1A1 P00352 6/20 0.64
MAPT P10636 3/20 0.64
LMNA P02545 2/20 0.64
HTT P42858 2/20 0.58
KDM4E B2RXH2 1/20 0.58
TP53 P04637 1/20 0.55
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
CYP2C19 P33261 1/20 0.55
MAPK1 P28482 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.50
TSHR P16473 2/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.49
KDM4C Q9H3R0 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1746713 0.81 TSHR (0.71) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL10872912 0.79 NPC1 (0.62) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL11188532 0.78 MAPT (1.00) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL13680524 0.76 MAPT (0.58) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL10692209 0.75 NPC1 (0.60) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL23385399 0.75 MAPK1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL14439016 0.74 CYP1A2 (0.62) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL25389377 0.73 CHRM5 (0.62) RAB9ASMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL25464930 0.72 LOXL2 (0.63) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT
SCHEMBL6580556 0.72 LOXL2 (0.63) RAB9ASMN1; SMN2NPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0194572-B1 HETEROCYCLIC SULFIDES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1992-01-02 EP disclosed